Head and Neck Cancer Clinical Trials
5 recruiting
Showing 1–20 of 32 trials
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Breast CancerLiver CancerEsophageal Cancer+35 more
UMC Utrecht8,000 enrolled18 locationsNCT04075305
Recruiting
Not Applicable
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Breast CancerHead and Neck CancerGastrointestinal Cancer+2 more
University of Chicago860 enrolled1 locationNCT04541381
Recruiting
Phase 2
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Breast CancerSarcomaLung Cancer+2 more
University of California, Irvine24 enrolled1 locationNCT07447050
Recruiting
DESTINY-PANTUMOUR04
Liver CancerEsophageal CancerPancreatic Cancer+24 more
AstraZeneca100 enrolled15 locationsNCT07124000
Recruiting
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Breast CancerEsophageal CancerProstate Cancer+10 more
Washington University School of Medicine100 enrolled1 locationNCT04354064
Recruiting
Not Applicable
Improving Care for Rural Patients With Solid Tumors
Breast CancerCervical CancerLung Cancer+5 more
University of Colorado, Denver320 enrolled14 locationsNCT04916990
Recruiting
Not Applicable
Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)
Triple-Negative Breast CancerOvarian CancerCervical Cancer+3 more
Institut Curie1,050 enrolled6 locationsNCT03017573
Recruiting
Phase 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Breast CancerEsophageal CancerGastric Cancer+11 more
Daiichi Sankyo740 enrolled84 locationsNCT06172478
Recruiting
Sample Collection for Ongoing Research and Product Evaluation Study
Breast CancerLiver CancerPancreatic Cancer+9 more
Natera, Inc.9,600 enrolled1 locationNCT07318051
Recruiting
Phase 1
Study to Assess the Effect of OCT-598 in Patients With Advanced Solid Tumors
Breast CancerHead and Neck CancerSolid Tumor
Oscotec Inc.51 enrolled3 locationsNCT07358806
Recruiting
Phase 2Phase 3
Trop2-targeted immunoPET Imaging of Solid Tumors
Liver CancerOvarian CancerCervical Cancer+11 more
RenJi Hospital400 enrolled1 locationNCT06851663
Recruiting
To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
Breast CancerHead and Neck CancerCancer+1 more
XEOS Medical850 enrolled1 locationNCT06970275
Recruiting
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Breast CancerOvarian CancerLung Cancer+15 more
University Health Network, Toronto2,500 enrolled1 locationNCT03702309
Recruiting
Phase 2
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Breast CancerSarcomaLung Cancer+6 more
British Columbia Cancer Agency200 enrolled2 locationsNCT04273061
Recruiting
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Esophageal CancerLung CancerHead and Neck Cancer+1 more
University of Colorado, Denver700 enrolled1 locationNCT00900419
Recruiting
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Breast CancerLiver CancerGastric Cancer+9 more
Washington University School of Medicine10 enrolled1 locationNCT06904365
Recruiting
Not Applicable
Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
Cervical CancerProstate CancerLung Cancer+2 more
The Netherlands Cancer Institute100 enrolled1 locationNCT06691776
Recruiting
Phase 2
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Breast CancerGastric CancerSarcoma+2 more
University of California, Irvine51 enrolled1 locationNCT06580002
Recruiting
Phase 3
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
Head and Neck CancerRenal Cell CarcinomaLung Cancer Metastatic
UNICANCER646 enrolled40 locationsNCT05078047
Recruiting
Phase 1
Brodalumab in the Treatment of Immune-Related Adverse Events
Breast CancerLiver CancerEsophageal Cancer+15 more
Brian Henick, MD11 enrolled1 locationNCT06673329